Assessing the Clinical Performance of Two Frequent Replacement Silicone Hydrogel Multifocal Toric Contact Lenses
- Conditions
- AstigmatismRefractive ErrorsPresbyopia
- Registration Number
- NCT05886907
- Lead Sponsor
- Alcon Research
- Brief Summary
The purpose of this clinical trial is to assess on-eye performance and overall fit of an investigational multifocal toric contact lens to aid in confirmation of the study lens design.
- Detailed Description
Subjects will attend 3 study visits with a planned individual duration of participation of up to 10 days.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 18
- Requires ADD (additional power for near vision);
- Currently wears multifocal soft contact lenses in both eyes during the past 3 months;
- Manifest cylinder power between -0.75 diopter (D) and -1.00 D;
- Best Corrected Visual Acuity (BCVA) of logMAR 0.10 (Snellen 20/25) or better in each eye.
- Other protocol-specified inclusion criteria may apply.
Key
- Any anterior segment infection, inflammation, or abnormality or disease (including systemic) that contraindicates contact lens wear, as determined by the Investigator;
- Any use of systemic or ocular medications for which contact lens wear could be contraindicated, as determined by the Investigator;
- Current or history of pathologically dry eye in either eye that, in the opinion of the Investigator, would preclude contact lens wear;
- Monovision contact lens wear.
- Other protocol-specified exclusion criteria may apply.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Primary Outcome Measures
Name Time Method Mean Distance Visual Acuity (VA) With Study Lenses Day 2, each wear period. A wear period was approximately 2 days. Visual Acuity (VA) was assessed binocularly (both eyes together) with study lenses in place at a distance of 4 meters using letter charts. VA was recorded in logarithm minimum angle of resolution (logMAR), where 0.0 logMAR equates to 20/20 Snellen (normal distance eyesight). A lower number indicates better visual acuity. No hypothesis testing is pre-specified for this endpoint.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Johns Creek Research Clinic
🇺🇸Johns Creek, Georgia, United States
Johns Creek Research Clinic🇺🇸Johns Creek, Georgia, United States